In order to investigate insulin response in diabetes mellitus, the glucose loading test has been widely employed. However, as reported previously (Ohneda et al. 1974) , it is usually very difficult to discriminate diabetes mellitus from the normal condition in view of insulin response. In 1974, we reported that the plasma insulin level 30 min after glucose load was significantly decreased in diabetes mellitus compared with the normal controls when glucose was given 60 min after tolbu t-amide administration (0hneda et al. 1974). Furthermore, a decrease in the maximal insulin response was observed in diabetes mellitus when glucagon was administered 60 min after tolbutarnide injection (Ohneda et al. 1975b ). Therefore, in this study tolbutamide-glucose loading and tolubtamide-glucagon test were carried out in subclinical diabetes, to see if decreased response of plasma insulin can be detectable as observed in overt diabetes. In the study, there was no decreased response of plasma insulin during GTT in subclinical diabetes compared with the normal controls. In fact, the mean levels of plasma insulin during GTT in the subclinical diabetics were significantly higher at 60 through 120 min than in the normal subjects. To the contrary, both the insulin levels at 90 niin in TGTT and the maximal response of plasma insulin to glucagon in TGT were decreased in the subclinical diabetics. Furthermore, the 90-min insulin levels during TGTT were significantly lowered in the patients with severe diabetes compared with the normal controls. This was true in the case of the maximal insulin response to glucagon in TGT. These results indicate that the decreased insulin response can be demonstrated even in the subclinical diabetics during TGTT or TGT.
SUBJECTS AND METHODS
Since significantly decreased responses were observed in plasma insulin during TGTT or TGT, but not during GTT, pretreatment with tolbutamide may magnify the decreased insulin response in diabetes mellitus. As tolbutamide seems to stimulate the release of stored insulin in the B cells of the pancreatic islets (Grodsky et al. 1968 ), successive administration of glucose or glucagon might induce insulino -genesis and/or the release of newly synthesized insulin in the B cells. In the normal controls, insulin levels at 90 min during TGTT were higher than those at 30 min during GTT (Ohneda et al. 1974 ). In contrast, insulin response to glucose or glucagon in subclinical diabetes was not exaggerated by the previous injection of tolbutamide but rather decreased. Therefore, the decreased response of plasma insulin to glucose or glucagon during TGTT or TGT in the subclinical diabetics supports the previous conclusion that in:sulinogenesis in the B cells of the islets is, in general, decreased in diabetes mellitus (Ohneda et al. 1974 ).
